Insights into the structure, mechanism, and regulation of scavenger mRNA decapping activity. 2004

Meigang Gu, and Carme Fabrega, and Shin-Wu Liu, and Hudan Liu, and Megerditch Kiledjian, and Christopher D Lima
Structural Biology Program, Sloan-Kettering Institute, New York, NY 10021, USA.

Complete removal of residual N-7 guanine cap from degraded messenger RNA is necessary to prevent accumulation of intermediates that might interfere with RNA processing, export, and translation. The human scavenger decapping enzyme, DcpS, catalyzes residual cap hydrolysis following mRNA degradation, releasing N-7 methyl guanosine monophosphate and 5'-diphosphate terminated cap or mRNA products. DcpS structures bound to m(7)GpppG or m(7)GpppA reveal an asymmetric DcpS dimer that simultaneously creates an open nonproductive DcpS-cap complex and a closed productive DcpS-cap complex that alternate via 30 A domain movements. Structural and biochemical analysis suggests an autoregulatory mechanism whereby premature decapping mRNA is prevented by blocking the conformational changes that are required to form a closed productive active site capable of cap hydrolysis.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009690 Nucleic Acid Conformation The spatial arrangement of the atoms of a nucleic acid or polynucleotide that results in its characteristic 3-dimensional shape. DNA Conformation,RNA Conformation,Conformation, DNA,Conformation, Nucleic Acid,Conformation, RNA,Conformations, DNA,Conformations, Nucleic Acid,Conformations, RNA,DNA Conformations,Nucleic Acid Conformations,RNA Conformations
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D004722 Endoribonucleases A family of enzymes that catalyze the endonucleolytic cleavage of RNA. It includes EC 3.1.26.-, EC 3.1.27.-, EC 3.1.30.-, and EC 3.1.31.-. Endoribonuclease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

Meigang Gu, and Carme Fabrega, and Shin-Wu Liu, and Hudan Liu, and Megerditch Kiledjian, and Christopher D Lima
May 2006, Trends in biochemical sciences,
Meigang Gu, and Carme Fabrega, and Shin-Wu Liu, and Hudan Liu, and Megerditch Kiledjian, and Christopher D Lima
November 2005, Molecular and cellular biology,
Meigang Gu, and Carme Fabrega, and Shin-Wu Liu, and Hudan Liu, and Megerditch Kiledjian, and Christopher D Lima
January 2011, Wiley interdisciplinary reviews. RNA,
Meigang Gu, and Carme Fabrega, and Shin-Wu Liu, and Hudan Liu, and Megerditch Kiledjian, and Christopher D Lima
January 2017, Wiley interdisciplinary reviews. RNA,
Meigang Gu, and Carme Fabrega, and Shin-Wu Liu, and Hudan Liu, and Megerditch Kiledjian, and Christopher D Lima
February 2005, Current opinion in structural biology,
Meigang Gu, and Carme Fabrega, and Shin-Wu Liu, and Hudan Liu, and Megerditch Kiledjian, and Christopher D Lima
September 2004, RNA (New York, N.Y.),
Meigang Gu, and Carme Fabrega, and Shin-Wu Liu, and Hudan Liu, and Megerditch Kiledjian, and Christopher D Lima
June 2014, Biochimica et biophysica acta,
Meigang Gu, and Carme Fabrega, and Shin-Wu Liu, and Hudan Liu, and Megerditch Kiledjian, and Christopher D Lima
January 2010, Wiley interdisciplinary reviews. RNA,
Meigang Gu, and Carme Fabrega, and Shin-Wu Liu, and Hudan Liu, and Megerditch Kiledjian, and Christopher D Lima
October 2019, ACS omega,
Meigang Gu, and Carme Fabrega, and Shin-Wu Liu, and Hudan Liu, and Megerditch Kiledjian, and Christopher D Lima
June 2008, RNA (New York, N.Y.),
Copied contents to your clipboard!